🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesNNT for MACE prevention — July 2024 Page 2

NNT for MACE prevention — July 2024

gary_naperville Tue, Dec 17, 2024 at 10:59 AM 36 replies 1,910 viewsPage 2 of 8
PharmacoVig_BOS
Senior Member
1,567
8,901
Feb 2024
Boston, MA
Dec 17, 2024 at 7:12 PM#6
FDA_TrackerJim said:
I want to bring up the cardiovascular angle on cardiovascular risk.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The "earlier than weight loss explains" argument is weaker than this thread makes it sound. Blood pressure and inflammatory markers move fast and are downstream of early weight loss, so the mechanism is not as cleanly separable as the summaries imply.

I would rather be corrected than agreed with, if it comes to it.

14 17amsterdam_pete, LondonLisa, mike_nyc and 11 others
Reply Quote Save Share Report
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Dec 17, 2024 at 10:26 PM#7
gary_naperville said:
My reason for being on this is cardiovascular rather than cosmetic, which puts me in a small minority in most of these threads.

Senior perspective on cardiovascular risk: I'm 68 years old and started this journey skeptically. My internist recommended it after years of failed interventions.

12 months later: down 36 lbs, more mobile, pain reduced, medications simplified. My quality of life has improved dramatically. I wish this existed 20 years ago.

To other older adults hesitating: the SELECT trial proved benefit in our age group. You deserve to feel good in your body regardless of age.

15 18stefan_berlin, Dr.EM_Chicago, pete_RVA and 12 others
Reply Quote Save Share Report
LibrarianMeg
Senior Member
1,678
7,890
Mar 2024
Baltimore, MD
Dec 18, 2024 at 1:40 AM#8
PharmacoVig_BOS said:
The "earlier than weight loss explains" argument is weaker than this thread makes it sound.

I'm 62 years old and want to share my perspective on cardiovascular risk as an older member of this community.

My doctor was initially hesitant because of my age, but the SELECT trial included patients up to 72 and showed consistent benefit across age groups. We started at the lowest dose with closer monitoring.

14 months later: down 61 lbs, off atorvastatin, A1C from 8.2% to 5.2%. My cardiologist is thrilled. cardiovascular risk is absolutely relevant for older adults — don't let anyone tell you otherwise.

16 19julia.endo, JessicaM_2024, TomFromTexas and 13 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
DerekSJ_a1c
Member
378
1,678
Aug 2024
San Jose, CA
Dec 18, 2024 at 4:54 AM#9

A narrower follow-up, since the general answer is now clear:

What did you change at the same time, and can you separate the two now?

17 20traveltech_sara, AttorneyGrant, DebRD_ATL and 14 others
Reply Quote Save Share Report
gary_naperville
Member
245
1,123
Oct 2024
Naperville, IL
Dec 18, 2024 at 8:27 PM#10
LibrarianMeg said:
I'm 62 years old and want to share my perspective on cardiovascular risk as an older member of this community.

Continuous metabolic monitoring dashboard for cardiovascular risk — I track everything in a spreadsheet and here's the month-over-month trend for my key markers:

Weight: consistent downtrend, -1.9 lbs/week average
Fasting glucose (finger stick): stable at 84 mg/dL
Blood pressure (home): 119/74 average
Resting heart rate: 64 bpm (down from 80)
Waist circumference: down 14 inches total

The resting heart rate improvement correlates with cardiovascular fitness gains. Everything is moving in the right direction.

17 15RickReta_CO, PharmHunterJen, TomTeleRx and 14 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register